Antibody Engineering and Therapeutics Asia

Memo

Antibody Engineering and Therapeutics Asia, produced by the same organizers as the prestigious Antibody Engineering and Therapeutics USA (San Diego) and Antibody Engineering and Therapeutics EUROPE (Amsterdam), this new conference will bring together renowned industry and academic scientists from around the world to share discovery and development technologies and strategies in the areas of antibody and protein engineering and therapeutics, antibody-drug conjugates (ADCs), bispecifics and immuno-oncology programs. A key feature of the event will be data presented in numerous case studies about preclinical and clinical programs, in which speakers will share lessons learned and challenges overcome. The event will feature a keynote session, speaker presentations, a scientific poster session, an exhibit hall of antibody/protein therapeutic-related products and services, as well as networking activities including an attendee dinner and cocktail reception.  Tickets: https://go.evvnt.com/355504-1?pid=5569  Date and Time: On Tuesday February 26, 2019 at 9:00 am ends Thursday February 28, 2019 at 5:00 pm Venue details: Hilton Tokyo Bay, 1-8 Maihama, Urayasu-shi, 279-0031, Japan Prices:Industry Conference Only: USD 2159.0,Academic Conference Only: USD 1079.0 Speakers: Tomoyuki Igawa, PhD, CEO and Research Head, Chugai Pharmabody Research, Junichi Koga, PhD, Head of RandD Division, Executive Officer, Daiichi Sankyo, Jochen Salfeld, PhD, Vice President Global Biologics, AbbVie Bioresearch Center, Kouhei Tsumoto, PhD, Professor and Director, The University of Tokyo